Latest Single photon emission computed tomography Stories
CHICAGO, Aug. 16, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC) a leading molecular imaging healthcare company is pleased to announce the use of their Attrius system at Caring Heart and Brain Imaging Inc., of Manasquan, New Jersey, which now offers Amyvid PET scans to identify the presence of plaque in the brain, which has been shown to be a precursor to Alzheimer's disease. Amyvid(TM) (Florbetapir F-18 Injection) is indicated for Positron Emission Tomography (PET) imaging...
NEWPORT NEWS, Va., Aug. 15, 2012 /PRNewswire/ -- Molecular Breast Imaging (MBI), also known as Breast-Specific Gamma Imaging (BSGI), is a breast imaging procedure performed using a tracer which accumulates in cancer cells making them detectable with special imaging systems. Several studies have demonstrated its ability to detect cancers missed by mammography and ultrasound, and now researchers are performing studies at lower doses in hopes of confirming a method to reduce the overall...
In the news release, Rockland Technimed Ltd. Presents Oxy-17® Metabolic Magnetic Resonance Imaging Technology at 2012 Brain Energy Metabolism and Blood Flow Gordon Research Conference, issued Aug. 15, 2012 by Rockland Technimed Ltd. over PR Newswire, we are advised by the company that the phone number provided for the media contact was incorrect. The correct media contact phone number is +1-201-512-8721, or +1-845-426-3406. The complete, corrected release follows: Rockland Technimed Ltd....
WATERVILLE, Maine, Aug. 15, 2012 /PRNewswire/ -- Rockland Technimed Ltd., a pioneer in developing metabolic magnetic resonance imaging (MRI) media, today presented the latest research on the potential clinical applications of brain MRI performed with its patented imaging medium, Oxy-17(®). The presentation highlighted the use of Oxy-17(® )MRI to measure two key indicators of cerebral tissue function: cerebral metabolic rate of oxygen (CMRO(2)) and oxygen extraction fraction (OEF)....
FARMINGTON, Conn., Aug. 8, 2012 /PRNewswire-iReach/ -- Medical imaging is a highly advanced technology segment in the already-advanced medical diagnostics market, encompassing everything from MRI to CT, from X-Ray to Ultrasound equipment. As the BRIC nations (Brazil, Russia, India, and China) continue their march toward modernization, the market for such advanced equipment will continue to grow. As these economies - and the rest of the world - emerge from recession into a new period of...
DULLES, Va. and MUMBAI, India, Aug. 6, 2012 /PRNewswire/ -- IBA Molecular and Piramal Imaging SA (Piramal) have announced an agreement whereby IBA Molecular will manufacture and distribute 18F-Florbetaben, Piramal's new diagnostic imaging agent, in the European and US markets. 18F- Florbetaben is a radiopharmaceutical currently in development for use with positron emission tomography (PET) for the detection of beta-Amyloid plaque deposition in the brain, a pathological feature...
MALVERN, Pa., July 24, 2012 /PRNewswire/ -- Siemens Healthcare (NYSE: SI) has announced that the MAGNETOM Spectra 3 Tesla MRI system has received clearance from the U.S. Food and Drug Administration (FDA). The latest addition to Siemens' internationally renowned portfolio of MRI solutions, the MAGNETOM Spectra system offers premium imaging at a reduced total cost of ownership compared to other scanners in this product range, providing hospitals and radiological institutes with...
LOS ANGELES, July 3, 2012 /PRNewswire/ -- MedQIA has developed a bone scan analysis package within our 510 (k) - cleared Imaging Biomarker Information System (IBIS). It includes a new automated technique for detecting lesions on bone scans that involves intensity normalization, thresholding, and connected-component analysis. The system calculates quantitative metrics for assessing disease burden and treatment response including total Bone Scan Lesion Area (BSLA), Bone Scan Lesion...
MALVERN, Pa., June 13, 2012 /PRNewswire/ -- Siemens Healthcare (NYSE: SI) has announced that the Food and Drug Administration (FDA) has cleared the SOMATOM® Perspective - an advanced 128-slice computed tomography (CT) scanner engineered to drive efficiency and reduce costs. The SOMATOM Perspective is designed especially for community hospitals, critical access hospitals and outpatient centers, offering the ability to extend the range of available examinations to their communities...
Study finds that a combination of molecular imaging, radiography and dual imaging probes detects more cancerous bone lesions than other methods Research revealed at the Society of Nuclear Medicine's 2012 Annual Meeting describes new approaches to imaging for the detection of tumors in complex cases of bone cancer. Hybrid imaging technology combining computed tomography (CT) with molecular imaging agents targeting two different markers of disease came out on top of the list for the...
